Related references
Note: Only part of the references are listed.Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Chemoradiotherapy in malignant glioma: Standard of care and future directions
Roger Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Safety, tolerability, QTc evaluation, and pharmacokinetics of single and multiple doses of enzastaurin HCl (LY317615), a protein kinase C-β inhibitor, in healthy subjects
Pamela A. Welch et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Phase I pharmacokinetic and pharmacodynamic study of the oral protein kinase C β-inhibitor enzastaurin in combination with gemcitabine and cisplatin in patients with advanced cancer
Jeany M. Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2007)
Synergistic antiglioma activity of radiotherapy and enzastaurin
Ghazaleh Tabatabai et al.
ANNALS OF NEUROLOGY (2007)
The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas
David E. Gerber et al.
NEURO-ONCOLOGY (2007)
New approaches to molecular cancer therapeutics
Ian Collins et al.
NATURE CHEMICAL BIOLOGY (2006)
Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer
Michael A. Carducci et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The protein kinase Cβ-selective inhibitor, enzastaurin (LY317615.HCI), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts
JR Graff et al.
CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice
KA Keyes et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
PKC-η mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways
SE Aeder et al.
ONCOGENE (2004)
Protein kinase C βII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion
Y Kawakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Protein kinase C ζ isoform is critical for proliferation in human glioblastoma cell lines
AM Donson et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Share Paper
